Health : Page 47
January 6, 2023
AstraZeneca’s Biologics License Application (BLA) for nirsevimab has been accepted for review by the US Food and Drug Administration (FDA) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants entering or during their first RSV season, and for children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season.
January 5, 2023
Malta is to begin vaccinating children as young as six months, Health Minister Chris Fearne said on Wednesday.
January 3, 2023
Hansa Biopharma announces that it has attained reimbursement in the Czech Republic for its first-in-class treatment, Idefirix, for the desensitization treatment of highly sensitized adult patients prior to kidney transplant from a deceased donor.
January 3, 2023
Datar Cancer Genetics announced that the US Food and Drug Administration (FDA) has granted \'Breakthrough Device Designation\' for its \'TriNetra-Glio\', a blood test to help in the diagnosis of brain tumors.
December 31, 2022
The NHS is struggling to cope with the “twindemic†of COVID and flu, as the number of patients in hospital with flu rose by 80% in a week, the latest data from NHS England show.
December 31, 2022
Novavax announced the initiation of a Phase 2 trial for its COVID-19-Influenza Combination (CIC) and influenza stand-alone vaccine candidates.
December 30, 2022
About 7 million children under five years of age have been vaccinated against polio or poliomyelitis this year in Mozambique, with at least 31 million doses of the vaccine made available, the country\'s largest daily paper Jornal Noticias reported.
December 29, 2022
The public will have faster access to life-saving defibrillators as the British government announces a new £1 million fund to increase the number of Automated External Defibrillators (AEDs) in communities most in need providing an estimated 1,000 new defibrillators in community spaces across England.
December 29, 2022
Uzbekistan’s health ministry has said at least 18 children have died after consuming a medicinal syrup manufactured by Indian drugmaker Marion Biotech.
December 28, 2022
AstraZeneca’s Calquence (acalabrutinib), a selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in Japan for the treatment of adult patients with treatment-naïve chronic lymphocytic leukaemia (CLL) (including small lymphocytic lymphoma [SLL]).
December 27, 2022
Nanobiotix announced the first patient in the United States has been randomized in NANORAY-312, a global Phase 3 registrational trial evaluating NBTXR3 for the treatment of elderly patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) who are ineligible for platinum-based chemotherapy.
December 27, 2022
Doctors are calling on the Government to crack down on high-sugar baby and toddler food pouches, branding the lack of nutritional guidance for infant products a “national disgraceâ€.